Evolent Health, Inc. (EVH)
Evolent Health provides specialty care management and health plan administration services to payers and healthcare providers. It last closed at $4.62 on Nov 17, down 4.25% on the day. The average 12-month price target from 2 analysts is $6.50 (+40.7% from the last close), with a high of $7.00 and a low of $6.00.
Key Stats
Last 12 monthsNot reported for this period.
From EVH's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.
Earnings
Full earnings history →Analyst Ratings & Price Targets
Analyst Ratings →Based on 2 analysts who set a price target on EVH in the past 90 days. The average target is $6.50, with a high of $7.00 and a low of $6.00, compared with the last close of $4.62.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Nov 6 | Oppenheimer | Maintained | Buy | $7 |
| Nov 5 | Needham | Maintained | Buy | $6 |
| Aug 18 | JP Morgan | Maintained | Buy | $6 |
| Aug 17 | TD Cowen | Target raised | Buy | $5 → $6 |
| Aug 12 | Truist Securities | Target lowered | Hold | $7 → $6 |
Technical Analysis
The stock sits between its 20 and 50 day averages. It is 15% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 51). The nearest support is the Pivot S1 at $4.53, and the nearest resistance the 20 day average at $4.63.
| RSI (14) | 51.50 | Middle of its range | Neutral |
| MACD | 0.13 | Below its signal line | Bearish |
| Stochastic | 75.6 | Middle of its range | Neutral |
| ADX (14) | 23.6 | Weak trend | |
| Williams %R | -42.1 | Oversold below −80, overbought above −20 | Neutral |
| CCI (20) | 17.3 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | +7.4% | Change over 10 sessions | Bullish |
| ATR (14) | $0.31 | Typical daily range, 6.7% of price |
| RSI (14) | 52.39 | Middle of its range | Neutral |
| MACD | 0.07 | Above its signal line | Bullish |
| Stochastic | 78.0 | Middle of its range | Neutral |
| ADX (14) | 14.6 | No clear trend | |
| Williams %R | -27.8 | Oversold below −80, overbought above −20 | Neutral |
| CCI (20) | 42.9 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | +10.3% | Change over 10 sessions | Bullish |
| ATR (14) | $0.69 | Typical daily range, 14.9% of price |
What happened before
See how EVH did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How EVH has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2015.
Whale Options Flow
90DNo whale options trades in EVH in the last 90 days.
EVH Institutional Ownership
Full report →- ●98 buying vs 103 selling
- ▼Held by funds -4.9 pts
- ▼Funds holding -5
- ▲Superinvestors: 3 added, 0 cut
- ●Put/call not meaningful
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 196 | 201 | −2.5% |
| In funds' top 10 | 4 | 5 | −20.0% |
| Held by funds | 110.3% | 115.2% | −4.9 pts |
| New / increased | 31 / 67 | 35 / 69 | −5.8% |
| Reduced / sold out | 67 / 36 | 63 / 32 | +8.4% |
| Put/call ratio | 0.20 | 0.00 | – |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether EVH is in one of them and how their past EVH trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered EVH in an article yet. Here's the latest on the wider market.
EVH Congress Trades
All congress trades →| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Greg GianforteR · MT | Sell | $50K – $100K | May 11, 2020 | May 29, 2020 | 18 d |
| Greg GianforteR · MT | Buy | $100K – $250K | Oct 11, 2019 | Nov 27, 2019 | 47 d |
| Greg GianforteR · MT | Sell | $50K – $100K | Sep 10, 2019 | Oct 20, 2019 | 40 d |
| Greg GianforteR · MT | Buy | $15K – $50K | Dec 20, 2018 | Jan 23, 2019 | 34 d |
| Greg GianforteR · MT | Buy | $50K – $100K | Jun 7, 2018 | Jun 15, 2018 | 8 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Evolent Health
Evolent Health is a healthcare services company based in Arlington, Virginia. It helps health plans and other payers manage care for people with complex conditions such as cancer, heart disease and musculoskeletal problems. Its specialty care management service combines provider networks and clinical pathways with a technology platform that gives doctors feedback during treatment. The company also sells administrative services to health plans, including plan administration, pharmacy benefit management, risk management and analytics.
- Headquarters
- Arlington, VA



